E70.328
Other oculocutaneous albinism
Clinical Classification Guidelines
Inclusion Terms
- Cross syndrome
Medical Intelligence & Overview
Other oculocutaneous albinism, classified under ICD-10 code E70.328, is a rare genetic condition characterized by a lack of pigment in the skin, hair, and eyes. Unlike typical albinism, which affects the entire body uniformly, this form may present with variable degrees of depigmentation and is sometimes associated with other syndromes, such as Cross syndrome. The condition results from genetic mutations impacting melanin production, leading to distinctive physical features and potential health challenges. This guide provides an overview of causes, symptoms, diagnosis, and considerations related to this condition.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the enzymes responsible for melanin synthesis, primarily involving genes like TYR, OCA2, TYRP1, and SLC45A2. Inheritance is typically autosomal recessive, meaning a person needs to inherit mutated copies of the gene from both parents. Presence of genetic variations that are associated with syndromic forms of albinism, such as Cross syndrome, which involves additional genetic anomalies affecting development.
Key Symptoms: Significant reduction or absence of melanin leading to very light skin, hair, and eye color. Narrowed or decreased pigmentation in the irises, leading to light-colored or pale eyes. Increased sensitivity to sunlight (photophobia), due to reduced pigmentation in the eyes. Vision problems such as strabismus (crossed eyes), nystagmus (involuntary eye movements), or reduced visual acuity. Potential skin concerns, including increased susceptibility to sunburn and skin damage. Additional features depending on associated syndromes, like developmental delays or physical abnormalities if present.
Diagnostic & Treatment
Diagnosis Path: Diagnosing other oculocutaneous albinism involves a combination of clinical evaluation and laboratory tests. Examination includes detailed assessments of skin, hair, and eye pigmentation. Genetic testing can identify specific gene mutations related to albinism and related syndromes. An ophthalmologic exam is crucial to evaluate visual function and eye-related features. Sometimes, skin biopsy or molecular testing is used to confirm the diagnosis, especially in atypical cases or when associated syndromes are suspected.
Treatment Protocols: Sun protection: Regular use of broad-spectrum sunscreens, protective clothing, and sunglasses to prevent sunburn and skin damage. Vision care: Corrective lenses, magnifiers, and visual aids to assist with visual acuity problems. Regular eye exams: To monitor and address eye health and vision issues promptly. Genetic counseling: For affected individuals and their families to understand inheritance patterns and implications. Supportive therapies: Educational and developmental support if associated syndromes impact development. Research and emerging treatments: Ongoing studies aim to better understand and explore potential interventions for pigmentation and related issues.
Clinical Advice & FAQs
Billing Guidance
Is E70.328 a billable ICD-10 code?
Yes, E70.328 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E70.328?
Clinical documentation must specify the nature of Other oculocutaneous albinism and any associated comorbidities for accurate reporting.
Cite this Clinical Reference